In contrast, the frequency of BTLA+ cells significantly decreased in CD4 and CD8 TIL populations when compared with the respective peripheral blood populations across multiple cancer types from 74 of these cancer patients (Figures 2G,H, where esophageal, gastric, and colorectal cancers were analyzed together as “digestive tract cancers”). This evidence concerns the gene CD4 and colorectal cancer.